Editas Medicine
| Region | Nordamerika |
| ISIN | US28106W1036 |
| Sektor | Chemie & Pharma |
| Website | http://www.editasmedicine.com/ |
| Titel | Autor | Datum |
|---|---|---|
|
CRISPR/CAS9 - die "Genschere" könnte die Welt verändern!
12 Kommentare |
MMeier | vor ungefähr 8 Jahren |
| Titel | Datum |
|---|---|
| H.C. Wainwright raises Editas Medicine stock price target to $5 on pipeline progress | vor 14 Tagen |
| Why Editas Medicine Stock Was Skyrocketing This Week | vor 14 Tagen |
| Editas Medicine Shares Soar 35% On Synthetic Biology Market Growth Outlook | vor 15 Tagen |
|
Editas Medicine, Inc.: Editas Medicine Announces Second Quarter 2025 Results and Business Updates
Company to select lead development candidate in September; on track to file IND by mid-2026 and ... |
vor 16 Tagen |
| Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| E3 Metals (1 Artikel) | |
| Dialog Semiconductor (1 Artikel) | |
| Endeavour Silver (2 Artikel) | |
| Enerdynamic Hybrid Technologies (1 Artikel) | |
| Alle anzeigen | |